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Summary A stathmokinetic method has been used to determine the cell cycle parameters, particularly the
potential tumour doubling time, of a murine fat pad sarcoma. Additional information has been obtained by
determining the percentagc Qf labelled mitoses (PLM). A technique which simultaneously demonstrates
autoradiographically labelled S phase nuclei and histochemically localized acid phosphatase activity has also
been used at light microscope level to compare these parameters: acid phosphatase activity was demonstrated
in tumour cells and macrophages. Single cell deletion by apoptosis has been investigated as distinct from
necrosis. Condensed, dying apoptotic cells, have been found in proliferative areas of tumour that are not
under physiological stress. The analysis of apoptosis indicated a previously unsuspected variation in apoptotic
activity with tumour weight. Cell death by apoptosis initially rose as the tumour grew, but after the tumour
reached a threshold weight it declined dramatically, and finally remained stable. This may reflect an initial
attempt at autoregulation of tumour size which ultimately fails. Apoptosis was estimated to account for an
average of 7% of the total cell loss rate in this tumour.
Kinetic measurements of tumours indicate that cell
loss is a prominent feature of tumour populations
(Steel, 1977), but the precise mechanism and
significance of cell death are complex.
Morphologically, apoptosis and necrosis are two of
the modes by which cells in tumours may be seen
to die, and cell death by necrosis is acknowledged
as one of the principal contributors to the observed
cell loss. Necrosis has been postulated to occur by
severe toxic shock, or due to ischaemia and
hypoxia (Tannock, 1968), largely in central tumour
regions occuring at a fixed distance from each
vessel concerned, as the result of tumour pro-
liferation outstripping angiogenesis. The vascular
endothelium has been cited as the vulnerable
element in tumours (Denekamp, 1984), particularly
when considering therapy in human neoplasms,
depending on the antigenicity of the tumour. In
contrast to necrosis, cell death in tumours by the
process of apoptosis is less well understood; many
growing tumours exhibit the phenomenon (Kerr et
al., 1972; Searle et al., 1973). Apoptosis is a means
of single cell deletion, and may occur in the midst
of viable tumour cells in neighbouring proliferative
areas. This phenomenon appears to result from
processes regulated within the dying cell and it may
be triggered by low intensity toxic stimuli; it occurs
in induced preneoplastic and neoplastic liver lesions
in rats (Columbano et al., 1984). However, it
frequently occurs where cell death is a physio-
logical, homeostatically regulated phenomenon as
in normal development. Cell death also occurs as
the result of the activity of tumour necrosis factor
(Carswell et al., 1975), which damages tumour cells
while having no effect on normal cells. The level of
apoptosis has been found to be elevated in two
murine transplantable sarcomas after treatment
with tumour necrosis factor (Sarraf et al., 1986).
Macrophage/granulocyte killing (Weinberg &
Haney, 1983; Loewenstein & Gallily, 1984) and
natural killer and T-cell killing, respectively also are
effectors of cell death which may incur the
apoptotic process. In tumours, apoptosis is not
restricted to obviously ischaemic regions and its
presence raises interesting questions concerning the
regulation of tumour cell populations.
Apoptotic cells are physiologically and morpho-
logically different from necrotic cells. They shrink
and lose contact with healthy neighbouring cells
early in the cell death process; the cytoplasm and
nuclei characteristically form dense blebs.
Chromatin condensation in apoptotic nuclei of
thymocytes and some murine lymphoid cell lines is
associated with excision of nucleosome chains from
the nuclear chromatin through the activation of an
intracellular but non-lysosomal endonuclease
(Wyllie et al., 1984). The apoptotic fragments are
engulfed, either by neighbouring cells, or by macro-
phages, within which they undergo hydrolytic,
phagocytic degradation (Kerr et al., 1972). This
process was described for the deletion of
lymphocytes in the mouse thymus (Bowen & Lewis,
1980) in which the enzyme acid phosphatase is
involved.
The localization of acid phosphatase provides a
means to monitor the pattern and extent of degra-
dative hydrolase activity in viable and dying
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tumour cells. Expression of hydrolase activity is
often associated with involutional phenomena in
both tumour cells and in invading macrophages of
host origin. Localization may be largely as free
hydrolase sources in the former but lysosomal in
the kitter-.
The aim of this investigation was to analyse the
cell death compartment, and to achieve an estimate
of the contribution of apoptosis towards it in the
transplantable murine sarcoma SaF. To our
knowledge no quantitative study of apoptosis
during tumour growth has previously been under-
taken. In this paper its incidence has been measured
during the growth of the tumour and is correlated
with the less loss rate obtained from coincidental
cell kinetic analysis. The tumour growth
compartment was investigated by the stathmo-
kinetic method (Tannock, 1970; Aherne et al., 1977;
Wright & Appleton, 1980), and the percentage of
labelled mitoses (PLM) was also estimated
(Mendelsohn, 1960). Measurements of the tumour
growth rate and cell proliferation rate were thus
obtained.
Materials and methods
The murine fat pad sarcoma was studied in 9-week
old, female, CBA/Ht mice; tumours were supplied
and implanted by the CRC Gray Laboratory. Each
animal had been implanted with 0.3 ml of cell
suspension of the donor tumour at 106cells ml1,
obtained freshly from a suitable CBA/Ht mouse.
The inoculum was made by tumour homogenization
in a tissue grinder and the transplant was posi-
tioned on the rear flank of the animals, dorso-
laterally, after shaving the skin. The procedure was
performed under light anaesthesia by Penthrane.
To estimate the tumour growth rate, growth
curves were constructed from data obtained from
29 mice over a 21-day period. The gross weight of
tumour material and the net tumour weight were
measured after the death of each animal. Gross
weight was the total tumour weight, as excised, and
the net weight concerned as far as possible, prolifer-
ative tumour material only, after removal of overt
necrotic matter.
To deduce the cell birth rate 12 of these mice
were injected with vincristine for the stathmokinetic
investigation, 17 days post implant. Vincristine
sulphate (Sigma no. V-7377; 1 mgkg body wt) was
injected i.p. into each mouse (Aherne et al., 1977),
the optimal dose for this tissue. Two animals were
then killed by cervical dislocation at half-hour
intervals for 3 h. The data obtained from each time
sample were pooled and the mean was used for
each point on the resultant graph.
PLM analysis was performed on 30 tumours that
were excised between 12 and 17 days after implant,
when their average net weight was 350 mg. To
obtain this, animals were injected with tritiated
thymidine 46 Ci mmol-, 188mCi mg- 1 specific
activity (Amersham International PLC, England)
ip., I uCg- 1 body wt. They were then killed by
cervical dislocation, initially at 30min intervals and
then at hourly intervals over 24 h.
Apoptosis was investigated in the tumours that
had been weighed to construct the growth curves
(including those that were injected with vincristine)
and in those that were used in the PLM
investigation. In addition data for the apoptosis
investigation were provided by 27 further animals
bearing the same tumour, sacrificed before the
neoplasm had achieved 100mgwt.
Processing for histological examination involved
tumours being rapidly excised. Each was weighed,
first intact and then after the removal of all macro-
scopically evident necrotic material and associated
blood and debris. Each was then cut inso small
blocks and was rapidly immersed, for 2.5h, at 0'C
in fixative, and was processed according to the
method of Lewis and Bowen (1985). The fixative
used was 9:1 10% neutral buffered formalin to
acetone. The material was then washed for half an
hour in several changes of acetone, followed by
impregnation for 3h in several changes of metha-
crylate monomer (BDH Chemicals, Poole, Dorset,
UK) at room temperature. Each tumour sample
was blocked overnight under carbon dioxide with
activated methacrylate directly on to Bright micro-
tome chucks, in such a manner that little heat was
evolved in the polymerisation process. After a
suitable drying period the tumour sections were cut
at 3.0pm on a Bright microtome.
To facilitate the investigation of apoptosis, all
sections were incubated to demonstrate acid
phosphatase activity. The incubating medium was
made up according to the method of Barka and
Anderson (1962), with: (A) 5ml 0.1 M acetate
buffer pH5.0, added to 5mg of naphthyl AS-TR
phosphoric acid (Sigma) dissolved in 0.25 ml of
dimethyl sulphoxide; a fresh solution of sodium
nitrite was made up by adding 300mg of NaNO2
to 10ml of distilled water. To constitute solution
(B), 0.25ml of pararosaniline, already in HCI was
added to an equal volume of the sodium nitrite,
causing nitrous acid to be formed, and hence the
hexazotization of the pararosaniline; 5 ml of sodium
acetate were added, and the pH of the solution was
adjusted to 4.9 with drops of NaOH. Solution (A)
was added to solution (B) to form the complete
incubation medium. This medium was pipetted over
the tissue sections on the glass slides, and they were
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90min. The sections were then carefully washed of
the incubating medium in running tap water and
were rinsed in distilled water. Samples for the PLM
investigation were processed for autoradiography
by manual dipping in Ilford L4 photographic
emulsion. These slides were left to expose in total
darkness at 4°C for 28 days before development in
Ilford D19 developer. Staining of all sections was
with Mayer's haematoxylin for 10min with some
samples additionally stained in eosin for 30 sec. The
material was then mounted with glass coverslips
with Xam (BDH Chemicals, Poole, Dorset, UK).
In the tissue samples used for the stathmokinetic
investigation, cells were counted in sequential
optical areas of lOO1um diameter noting the gross
cell number, the number of arrested metaphases,
the number of apoptotic figures, and the number of
enzyme positive cells. For each sample the
minimum gross number of cells statistically
required was counted as described by Aherne et al.
(1977). This is an adjusted form of the original
equation derived by Puck and Steffen (1963); cell
counts were performed across sequential optical
areas of the tumours. At least 2235 cells were
counted for each tumour sample as indicated
above. Gross cell number and number of arrested
metaphases were counted in the 12 vincristine
treated samples. The 17 remaining mice necessary
to complete the apoptotic investigation acted as
controls to the stathmokinetic procedure, providing
the normal unarrested level of the mitotic index.
The stathmokinetic collection function of
1n(1 +Imet) was calculated where Imet is the meta-
phase index. Tangents were calculated for each
growth curve at the day 17 point, to estimate the
growth rate on the day of the metaphase
accumulation procedure.
In the tumour samples used for the PLM investi-
gation, Ag and enzyme activity were simul-
taneously demonstrated on the same sections. Cells
were once more counted in sequential optical areas,
of lOO1pm diameter in each tumour section, noting
the gross cell number and numbers of mitotic
figures, labelled mitoses, apoptotic figures and
enzyme positive cells. At least 100 mitoses were
counted per sample, noting the number of these
that were autoradiographically labelled; this
provided the percentage of labelled mitoses.
Gross cell number, and number of apoptotic
figures were counted in the small tumour samples
in the same manner in sequential optical areas.
Apoptotic figures were recognised by their
condensed chromatin and retraction from their
neighbours. Pink enzyme reaction product marked
acid phosphatase positive tumour cells and macro-
phages. The apoptotic index and the enzyme
positixvc index were calculated.
The linear graphs derived from the stathmo-
kinetic data providing the data on tumour birth
rate KB have been fitted to the experimental points
by regression of least squares. Tumour growth rate
KG was derived from the slope of the tangent to the
growth curve on day 17 of the investigation.
Tumour loss rate KL is the difference between the
cell birth rate and the tumour mass loss rate. The
cell loss factor 0 is the result of KL/KB. Methods
used to calculate the cell kinetic data were as
described in Aherne et al. (1977).
Curves have been fitted to the growth curves, the
PLM curves, and the data concerning the
relationship of apoptosis to net tumour weight,
according to adaptations of NAG Fortran graphics
supplement computer programmes, EO2ACF and
JO6EAF, adapted by Peksa and Sarraf. These are
numerical allegraphics routines used in the
Honeywell Multics computer systenii.
Results
Histological observations
Ischaemic necrotic tissue was found surrounded by
proliferative cells (Figure 1), although not
necessarily at the geographical centres of the
tumours. Apoptotic figures were present in prolifer-
ative areas near blood vessels (Figure 2) and had an
elevated incidence in areas in proximity to necrotic
foci. Within the necrotic zones themselves cell death
was too extensive to allow for unequivocal identifi-
cation of its various modes. Acid phosphatase
positive cells were present in the same area as
autoradiographically labelled S phase nuclei (Figure
3) and apoptotic debris could be discerned within
the phagosomes of macrophages, as in Figure 4. A
proportion of tumour cells, apoptotic bodies and
macrophages were acid phosphatase positive. No
single cell demonstrated both labels, indicating that
Figure I Low power micrograph showing .i necrotic
centre, C, surrounded by healthy tumouL- cells, T.
Blood vessels are also present V (H & F).992 C.E. SARRAF & I.D. BOWEN
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Figure 2 Blood vessel containing red blood cells, R.
There are apoptotic cells and fragments A close to the
vessel and mitotic figures M (H & E).
aX ........... ..... i
Figure 3 High power autoradiograph of a region with
a large macrophage, MAC, demonstrating the reaction
product of the enzyme acid phosphatase, RP. Silver
grains are seen over S phase nuclei, S. Reaction
product is also seen in some tumour cells, TC
(counterstained with haematoxylin only).
Figure 4 High power micrograph of a large macro-
phage, MAC, containing the reaction product of acid
phosphatase, RP. There are engulfed apoptotic
fragments present, A, within the macrophage
(counterstained with haematoxylin only).
there was little or no acid phosphatase in actively
proliferating cells.
The data used in the calculation of the stathmo-
kinetic collection function (Figure 5) appear in
Table I and the growth curves that provide the
tumour growth rate are represented in Figure 6.
The optimal dose of vincristine was administered
to the host animals so that all metaphases in the
population were arrested. The time of duration of
the experiment was selected to be short enough so
as not to allow the arrested metaphases to
degenerate before histological fixation (Aherne &
Challoner, 1983).
The PLM curve of the fat pad sarcoma SaF is
shown in Figure 7, and the results are tabulated in
Table II.
Simultaneous localization ofacidphosphatase
positive cells and Sphase nuclei
The cells that took up the tritiated thymidine were
demonstrated autoradiographically, and the acid
phosphatase positive cells were demonstrated histo-
chemically. The former were the cells that had been
in the S phase of the cell cycle at the time of
administration of the label.
The number of acid phosphatase positive cells,
and hence the enzyme positive index, was found to
initially increase as small tumours grew larger
(Table III). The enzyme index was then found to
stabilize at a mean of 0.143. Diffuse sources of
hydrolase were usually associated with apoptosis
and could be interpreted as evidence of lysis.
Phagocytosed apoptotic fragments contributed to
lysosomal macrophage activity.
Progression ofcell death by apoptosis in relation to
tumour mass
The first assessment of tumour weight and
apoptotic index was made 7 days after trans-
plantation of the tumour cells and the peak
occurred 11 days post implant. The apoptotic index
derived from each tumour sample was plotted
against the net weight of that tumour. This was
separately performed for tumours not treated with
vincristine. The levels of apoptosis in general were
higher in vincristine treated samples, but the trend
was the same in both.
The average apoptotic index for tumours over
100mg was 0.01 (Figure 8). Tumours 0 to 50mg
displayed an increase in apoptotic index with
increase in tumour weight, to a maximum apoptotic
index of 0.027.
Tumours from 50 to 100mg demonstrated a
decrease in apoptotic index with increase in tumourKINETICS OF A MURINE SARCOMA WITH APOPTOSIS 993
Table I Stathmokinetic procedure and tumour growth parameters
Apparent cell cycle time, tC(a)=30.53h
Cell birth rate, KB =0.0227 cellscell-1 h-
Gross Net
Tumour doubling time, tD 1.9 2.5 days
Tumour growth rate, KG 0.015 0.0113 cellscell 1h -
Tumour loss rate, KL 0.008 0.0114 cellscell 'h 1
Cell loss factor, 0 0.34 0.5
Growth fraction, tc/tc(a)=0.65
tc is the cell cycle time as derived from the PLM curve
These parameters have been deduced according to the methods described
by Aherne et al. (1977).
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Figure 5 Stathmokinetic investigation on the SaF
sarcoma 17 days after implant. Each point is the mean
of results involving 2 animals. The value of the rate of
entry into mitosis is directly readable from this graph,
and thus the cell birth rate.
weight. Tumours of above 100mg net wt then
demonstrated a stable level of apoptosis over a very
wide range of increasing tumour weights. An
enhancement of apoptosis thus precedes the
exponential tumour growth.
To assess the contribution of cell loss by
apoptosis to the overall cell loss rate, a number of
assumptions must be made, bearing in mind not
least, that the relationship of the rate of cell death
to the rate of cell loss from the tumour mass is a
complex one. However, by the method of
calculation of Wyllie (1975), the cell loss by
apoptosis can be seen to account for 7% of the
total cell loss rate (Appendix).
Lo
0 5 10 15 20
Days post implant
Figure 6 Growth curves of the SaF sarcoma over 19
days. The 'gross', total weight as incised, and 'net'
after the removal of overt necrotic material, values are
indicated. Twenty-nine tumours were included in the
growth curve data. The asterisks indicate the day on
which the stathmokinetic investigation was performed.
Discussion
For all investigations of proliferation, care was
taken to match tumours in size. Tumour cell popu-
lations can be considered to consist of the prolifer-
ative 'compartment', the cell loss 'compartment'
and the hypoxic 'compartment' although these
compartments are not physically discrete from each
other. With regard to the cell loss compartment,994 C.F. SARRAF & I.D. BOWEN
100
- 50
0L
0.03
x
C 002
0
0
a
o 001 o0
/ oX ~~~G,+ G2
0
t s- - + Mo
-tc
5 10 15 20 25
Hours post 3H thymidine
30
Figure 7 PLM curve, indicating a cell cycle time, t( of
19.8 h; the time spent in mitotis, tM is 1.3h; that in S
phlmse ts 13.0h, and the total in the G, and G2 phases,
5.5h. t=ts+G, +tM+G2. The graph was drawn with
the aid of NAF Fortran computer graphics supple-
ments EO2ACF and JO6AEF.
Table II Percentage of labelled mitoses
Cell cycle time, tc = 19.8 h
Average time spent in mitosis, tM = 1.3 h
Average time spent in S phase, ts = 13.0h
Growth fraction, tc/tc(a)
Average mitotic index, IM
0.65
0.014
tc(a) is the apparent cell cyle time as derived
from the stathmokinetic procedures.
These parameters have been deduced
according to the methods described by
Aherne et al. (1977).
Table III Localization of acid phosphatase
positive cells
Dal Average enzyme positive index
4-7 0.083
8-11 0.137
12-15 0.148
16-17 0.145
Plateau average=0.143
this paper has shown, that apoptosis accounts for
around 7% of the total cell loss.
The hypoxic compartment is composed of cells
which are alive, but due to their low metabolic
activity do not contribute to the same degree to
overall tumour growth. This becomes evident when
considering radiosensitivity; the hypoxic fraction
has a threefold greater resistance to radiation than
well oxygenated cells (Steel, 1977), suggesting that
their metabolic rate would be too lo\v for actiVe
0 0 0 0 0o
-M 0
1 100 200 300 400 500 600 700
Net tumour weight (mgms)
Figure 8 High level of apoptosis found in smaller
tumours. Apoptosis is found to be more constant at a
lower level in samples of larger tumours. This graph
was drawn with the aid of NAG Fortran computer
graphics supplements EOIACF and JO6EAF.
proliferation. It is noted that the results obtained
from the PLM investigation could be affected by
both fast cycling cells and non-cycling cells in the
population. The two techniques of stathmokinesis
and the PLM have been used in tandem to avoid
inaccuracy as far as possible.
The investigation of proliferation leads to the
estimation of the growth fraction, the tumour
doubling time and the cell loss factor 0. These
parameters indicate numerically that not all tumour
cells play a part in tumour growth and that in fact
a significant number are lost. The more accurate
estimation of the tumour doubling time and thus of
0, is from the net growth curve. The cell loss factor
represents the discrepancy between cell production
rate and total mass growth rate. When the gross
growth rate does not match the predicted growth
rate (from the metaphase accumulation data or
from the labelling index), then it may be attributed
to the cell loss from the tumour mass. If dead cells
remain within the tissue they are not included in
the value of Q. The difference in the values of Q
calculated with the data from the gross and net
growth curves correlates with the necrotic matter
discarded before the second weighing of each
tumour. A considerable component of cell loss is
doubtless that due to cell death by necrosis, but cell
death by apoptosis clearly plays an interesting and
important part.
It is not inconceivable that cell death in the
initial phases of tumour establishment could be as a
result of host immunogenic response to the implant;
however the phenomena described and enumerated
above adhere closely in their histological descrip-
tions to those described for apoptosis, principally
by Kerr et al. (1972), in healthy adult tissue where
the immune response has not been elicited. There
are morphological differences between apoptosis
and antibody plus complement killing that can
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usually be distinguished at the light microscope
level, and are unequivocal in the electron micro-
scope (Duvall & Wyllie, 1986). Such divergences in
the respective modes of cell death have been noted
in this and other experimental tumours at the
ultrastructural level (Sarraf & Bowen, unpublished).
Cell death in tumours caused by immune cyto-
toxicity may depend on the binding of a lympho-
cyte to the target tumour cell at some stage in the
process. The morphology of lysis of these target
cells is in good agreement with that seen in P185
cells attacked by cytotoxic thymus derived lympho-
cytes (CTL) (Russell et al., 1982); no initial binding
of the dying cell to an immune cell has been
observed here. In classical apoptosis there is con-
densation of the cytoplasm, margination and bleb-
bing of nuclear chromatin, and the apoptotic cell
retracts from its neighbours breaking intercellular
junctions. In response to antibody plus complement
mediated immune killing however, there is typically
cytoplasmic vacuolation and loss of structural
integrity of the inner nuclear membrane leading to
an electron lucent cell which retains contact with
its neighbours until the process of cell death is
advanced.
The boost in apoptosis that occurs in tumours in
their growth up to 50mg, corresponds to the lag in
tumour growth apparant from the early portions of
the growth curves. It indicates that initially mitosis
in tumour growth is to some extent off-set by the
increase in apoptosis. As the proliferation becomes
more extensive however, the apoptotic level de-
creases. A physiological control system could be in
operation that initially causes an increase in cell
death as mitosis increases. This might be compar-
able to the final balance achieved after chalone
control of liver size in response to experimental
amputation (Bullough, 1967). This apparent control
ceases to operate in the SaF tumour around 50mg
weight and above. The hormonal status of the host
also could be important; there is, for example,
hormonal control of the limitation in size and
eventual involution of the thymus (Weaver, 1955,
Bellamy et al., 1976). In the Walker 256 carcinoma,
it has been found that, as in the thymus, the
distribution of the highest rate of mitosis occurs at
the mean cell density, but at higher densities (that
result from elevated mitotic rates) cellular prolifer-
ation is inhibited (Bellamy & Hinsull, 1978). Thus a
complete investigation of the local and systemic,
chalone and hormonal effects on the level of apop-
tosis would doubtless be rewarding, to clarify these
points. The theoretical extrapolation of the line
indicating the initial rise in apoptosis, past that of
the 50mg mark would indicate the potential advan-
tage to tumour control that could be achieved if the
drop.Min the level of apoptosis couLl(d he preveiited. It
is possible that if the rate of increase of the level of
apoptosis were held at its maximum, it would lead
to total tumour control.
The results indicate that apoptosis may account
for an average of 7% of the cell loss rate depending
on the values of variable assumed parameters, even
in a tumour with considerable areas of necrosis.
The assumptions referred to earlier, depend in this
calculation on the cell loss at the time of the
maximum apoptotic index being totally due to
apoptosis. This is not unreasonable as angiogenesis
could be sufficient to prevent ischaemic necrosis in
tumours of between 20 and 50mg. The calculation,
however, may only be considered as an approxi-
mation, as the ratio of the diameters of apoptotic
and mitotic chromatin (rA and rM respectively)
are variable and it is assumed that the parts of
both mitotic and apoptotic cells that allow their
histological recognition are sufficiently near to
spherical for mean radii to be valid assumptions.
The equivalence of one apoptotic body per cell and
constant rates of entry into apoptosis and mitosis
have been assumed. The value of the calculation
perhaps is not in its precision, but in the demon-
stration that the rate of cell loss by this means is of
the right order to be assessed in conjunction with
classical kinetic calculations.
The incidence of apoptotis was found in general
to be higher in vincristine treated samples than in
untreated tumours. In addition to causing an
elevated level of apoptosis vincristine could also
affect either the speed of the progression of apop-
tosis, or the speed at which apoptotic debris is
phagocytosed. Either phenomenon would result in
the simultaneous presence of more apoptotic
bodies.
The extent of the involvement of the enzyme acid
phosphatase in cell death in this sarcoma is reflected
by the numerous hydrolytic events that were
observed. There was degradation of apoptotic
debris in apoptotic fragments themselves, and in
phagosomes in tumour cells and macrophages. The
occurrence of diffuse sources of acid phosphatase in
apoptotic cells and fragments can be taken as a
sign of lysis and impending cell death.
In general the role of acid phosphatase in cell
death is confirmed by Bowen (1984). Sylven and
Niemi (1972) found that the enzymes that hydrolyse
aminoacyl naphthylamides were increased in the
dying cells of several forms of tumour. It is clear
that there is an apparent increase in the number of
acid phosphatase positive cells following the
apoptotic peak; this would be expected in terms of
secondary phagocytosis of the elevated numbers of
apoptotic cells. The rate of phagocytosis of apop-
totic fragments would not depend solely on the rate
of arrival of acid phosphatase positive host derived996 C.E. SARRAF & I.D. BOWEN
cells, as tumour cells can phagocytose apoptotic
bodies, and these could account for the initial lower
incidence of acid phosphatase activity. A longer
tissue 'lifespan' of apoptotic bodies, as possibly
occurs in the vincristine treated samples would
result in a higher overall initial apoptotic index.
The relationship between acid phosphatase activity
and apoptosis is complex. The histochemical results
show that a diffuse reaction product is present
in apoptotic bodies at certain stages, but this
appears to be transient or phasic and may be linked
to the initial process of cell fragmentation. Macro-
phages show a clearly positive response and are
involved in the secondary phagocytosis of apoptotic
fragments. Acid phosphatase activity is therefore
relevant to impending cell death by apoptosis and
to subsequent phagocytosis. There' is obviously
some metabolic acid phosphatase activity associated
with lysosomes particularly in fibroblasts.
In conclusion, from the stathmokinetic data the
cell birth rate was found to be 0.0227 cells
cell-1 h-1, and the apparent cell cycle time was
found to be 30.53h; from the PLM data the real
cell cycle time was calculated as 19.8h. The
potential tumour doubling time was 2.5 days. The
investigation indicated that cell loss occurs in this
murine sarcoma with an overall cell loss factor of
0.5. The growth fraction of the tumour 17 days
after implant, calculated from data obtained
jointly from both the stathmokinetic procedure and
the PLM curve was 0.65. Measurements of the net
tumour growth parameters that did not include
blood and cell debris give rise to an accurate
estimation of the cell loss factor, growth fraction
and the tumour doubling time. The overall cell loss
rate was calculated as 0.0114 cellscell -1h-1, and
the contribution of apoptosis to this is probably in
the region of 7%.
The simultaneous method of demonstration of
acid phosphatase and proliferative cells, showed
that the enzyme was present in both macrophages
and dying apoptotic tumour cells, but not in actively
proliferative ones.
Apoptosis initially increases with tumour growth
almost to match mitosis but then falls to a constant
level over a wide range of increasing tumour
weights. It results from intracellularly regulated
processes and is potentially controllable in tumours.
If the rate of increase of apoptosis could be main-
tained to permanently off-set the rate of mitosis,
tumour growth would be prevented.
Appendix
Calculation of the contribution ofapoptosis to the
overall cell loss rate
Average net weight at maximum apoptotic
index=20mg, at day 11.
IA' =maximumapoptoticindex, 11 dayspostimplant.
IA =average apoptotic index, 17 days post implant.
NA rate ofentry into apoptosis 11 days post implant.
NA=rate ofentry into apoptosis 17 days post implant.
NM=rate of entry into mitosis.
tA =time spent in apoptosis.
tM =time spent in mitosis= 1.3h.
k =section thickness =3.0jum.
rA =radius of apoptotic nucleus=3.0jm.
rM =radius of mitotic nucleus=5.0gm.
nM =no. of cells in mitosis.
nA =no. of cells in apoptosis.
Growth and loss parameters
day 11
KB=0.021 cellscell-h 1
KG=0.019cellscell-1 h-. (unpublished data)
KL=0.002cellscell-h-.
IA' =0.027.
NIM =0.014.
Growi'th and loss paramneter.s
day 17
KB=0.0227cellscell-h '.
IA =0.011.
IM =0.014.
KL=0.0l14 cells cell h 1
The relative number of cells recognised as apoptotic
is the apoptotic index.
Assuming that apoptosis is responsible for all the
cell loss at day 11, then
NA'=KL at day 11.
Equation of
Wyllie (1975) (i)
NM nM tA(k+2rA)
NA nA tM(k +2rM)
Adaptation of
Wyllie's equation (ii)
KB IM, tA(k+2rA)
KL IA tM(k+2rM)
NM =KB
nM IM'
nA IA'
Thus, substituting in equation (ii),
0.021 0.014 tA(3 +2[3]) tAO.126
0.002 0.027 1.3(3+2[5]) 0.456
tA=38.1h
To find the average value of the rate of entry
into apoptosis, NA, restate equation (ii) to apply to
the parameters of day 17 post implant asKINETICS OF A MURINE SARCOMA WITH APOPTOSIS 997
KB IM tA(k+2rA) N-I tM(k+2r
...equation (iii) NA 'At(+2)
substituting in equation (iii),
0.0227 0.014 38.1(3+2[3])
NA 0.011 1.3(3+2[5])
0.0227 4.8
NA 0.159
NA=0.00075 cellscell- h1
This is thus the average cell loss rate due to
apoptosis that is in operation 17 days post implant.
The overall cell loss rate on day 17=
0.0114cellscell- 1 h-1.
Thus apoptosis on average accounts for 6.6% of
the overall cell loss in this sarcoma.
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